4
Changes in Ownership
FENNEC PHARMACEUTICALS INC. Filed Acc 0002043411-26-000004
Chief Strategy Officer acquired 19,165 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cioffi Christiana Marie Chief Strategy Officer | 2026-03-31 | Option exercise | +17,106 | 21,806 | D: show line 1 in the form | ||
| Cioffi Christiana Marie Chief Strategy Officer | 2026-03-31 | Option exercise | +158 | 21,964 | D: show line 2 in the form | ||
| Cioffi Christiana Marie Chief Strategy Officer | 2026-03-28 | Option exercise | +1,901 | 23,865 | D: show line 3 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cioffi Christiana Marie Chief Strategy Officer | 2026-03-31 | Grant or award · Stock Options | +120,000 | $5.77 | $692,400 | 265,300 | D: show line 4 in the form |
Loading xslF345X06/form4-04022026_040407.xml…